These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8533168)

  • 41. Apolipoprotein E alleles as risk factors in Alzheimer's disease.
    Roses AD
    Annu Rev Med; 1996; 47():387-400. PubMed ID: 8712790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular genetics of Alzheimer's disease.
    St George-Hyslop PH
    Biol Psychiatry; 2000 Feb; 47(3):183-99. PubMed ID: 10682216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.
    Schupf N; Patel B; Silverman W; Zigman WB; Zhong N; Tycko B; Mehta PD; Mayeux R
    Neurosci Lett; 2001 Apr; 301(3):199-203. PubMed ID: 11257432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.
    Rogaeva E
    Neuromolecular Med; 2002; 2(1):1-10. PubMed ID: 12230301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic determinants of Alzheimer disease.
    St George-Hyslop P
    Prog Clin Biol Res; 1995; 393():139-45. PubMed ID: 8545447
    [No Abstract]   [Full Text] [Related]  

  • 46. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. APOE is linked to Alzheimer's disease in a large pedigree.
    Cai X; Fallin D; Stanton J; Scibelli P; Duara R; Crawford F; Mullan M
    Am J Med Genet; 1997 Jul; 74(4):365-9. PubMed ID: 9259370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families.
    Liu L; Forsell C; Lilius L; Axelman K; Corder EH; Lannfelt L
    Am J Med Genet; 1996 May; 67(3):306-11. PubMed ID: 8725748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New piece in Alzheimer's puzzle.
    Travis J
    Science; 1993 Aug; 261(5123):828-9. PubMed ID: 8346434
    [No Abstract]   [Full Text] [Related]  

  • 50. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
    Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
    Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The genetics of Alzheimer disease.
    Steele CD
    Nurs Clin North Am; 2000 Sep; 35(3):687-94. PubMed ID: 10957683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
    Schmechel DE; Saunders AM; Strittmatter WJ; Crain BJ; Hulette CM; Joo SH; Pericak-Vance MA; Goldgaber D; Roses AD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9649-53. PubMed ID: 8415756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dancing in the dark? The status of late-onset Alzheimer's disease genetics.
    Bertram L; Tanzi RE
    J Mol Neurosci; 2001 Oct; 17(2):127-36. PubMed ID: 11816786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene mutations in inherited amyloidopathies of the nervous system.
    Tanzi RE
    Am J Hum Genet; 1991 Sep; 49(3):507-10. PubMed ID: 1831958
    [No Abstract]   [Full Text] [Related]  

  • 55. The impact of risk factors of Alzheimer's disease in the Down syndrome.
    Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic and host factors for dementia in Down's syndrome.
    Schupf N; Sergievsky GH
    Br J Psychiatry; 2002 May; 180():405-10. PubMed ID: 11983636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
    Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC;
    Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
    Mann DM; Iwatsubo T; Pickering-Brown SM; Owen F; Saido TC; Perry RH
    Neurosci Lett; 1997 Jan; 221(2-3):81-4. PubMed ID: 9121705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.